Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 4Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 312Carcinoma, Non-Small-Cell Lung 282Prostatic Neoplasms 161Colorectal Neoplasms 155Carcinoma, Hepatocellular 145Neoplasms 135Leukemia, Myeloid, Acute 132Lung Neoplasms 115Squamous Cell Carcinoma of Head and Neck 107Triple Negative Breast Neoplasms 103Multiple Myeloma 101Recurrence 99Pancreatic Neoplasms 94Stomach Neoplasms 93Neoplasm Metastasis 87Ovarian Neoplasms 86Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Esophageal Neoplasms 67Uterine Cervical Neoplasms 66Melanoma 65Brain Neoplasms 65Head and Neck Neoplasms 63Rectal Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 58Lymphoma 55Myelodysplastic Syndromes 54Esophageal Squamous Cell Carcinoma 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Giant Cell Tumor of Tendon Sheath × Clear all
NCT07499362 2026-05-28

Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Phase 2 Recruiting
20 enrolled

Giant Cell Tumor of Tendon Sheath

Data powered by HemOnc (CC BY 4.0) Colophon âš¡